Ponatinib both as an effective bridge to allogeneic hematopoietic stem cell transplantation and as posttransplant maintenance therapy in a chronic myeloid leukemia patient with myeloid blast crisis.

Küçükyurt, Selin; Kelezoglu, Alihan; Elverdi, Tugrul; Özmen, Deniz; Ar, Muhlis Cem; Eskazan, Ahmet Emre

Küçükyurt, Selin; Kelezoglu, Alihan; Elverdi, Tugrul; Özmen, Deniz; Ar, Muhlis Cem; Eskazan, Ahmet Emre.

Afiliação

Küçükyurt S; Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Kelezoglu A; Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Elverdi T; Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Özmen D; Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Ar MC; Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Eskazan AE; Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. Electronic address: emre.eskazan@iuc.edu.tr.

Hematol Transfus Cell Ther ; 45(2): 275-277, 2023.

Article em En | MEDLINE | ID: mdl-34210618

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Hematol Transfus Cell Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google